Skin Problems in School Children and Adolescents: An Update Daniel - - PowerPoint PPT Presentation

skin problems in school children and adolescents an update
SMART_READER_LITE
LIVE PREVIEW

Skin Problems in School Children and Adolescents: An Update Daniel - - PowerPoint PPT Presentation

Skin Problems in School Children and Adolescents: An Update Daniel Krowchuk, M.D. Departments of Pediatrics and Dermatology Wake Forest School of Medicine Round Things Border well defined, elevated, and red Scale Tinea Corporis (Ringworm)


slide-1
SLIDE 1

Skin Problems in School Children and Adolescents: An Update

Daniel Krowchuk, M.D.

Departments of Pediatrics and Dermatology Wake Forest School of Medicine

slide-2
SLIDE 2

Round Things

slide-3
SLIDE 3

Border well defined, elevated, and red Scale

slide-4
SLIDE 4

Tinea Corporis (Ringworm)

  • Spread by direct contact,

fomites, occasionally from dogs or cats

  • Treatment

– Topical: miconazole, clotrimazole, others – Oral: griseofulvin, terbinafine

slide-5
SLIDE 5

Tinea Corporis

slide-6
SLIDE 6
  • Border not elevated
  • Crust, not scale
  • No central clearing
slide-7
SLIDE 7

Nummular Eczema

  • Variant of atopic dermatitis
  • Treated with an emollient and

topical corticosteroid

slide-8
SLIDE 8
  • Erythematous

plaque (no central clearing)

  • Thick scale
  • Scalp involvement
  • Sharply marginated

Psoriasis

slide-9
SLIDE 9

Psoriasis

  • Likely the result of a

genetic predisposition and an environmental trigger (infection, trauma)

  • Initial treatment is with a

topical corticosteroid

Bleeding at the site

  • f scale removal

(Auspitz sign)

slide-10
SLIDE 10

DermAtlas

  • Ring and incomplete

central clearing

  • No scale
  • Border elevated and

firm

slide-11
SLIDE 11

Granuloma Annulare

DermAtlas

  • Cause unknown
  • No treatment needed; resolves

spontaneously

slide-12
SLIDE 12

DermAtlas

slide-13
SLIDE 13

Erythema Migrans (Lyme Disease)

  • Most common manifestation of Lyme

disease (early localized stage)

  • Begins as an erythematous papule or

macule that enlarges to >5 cm in diameter over days to weeks

– Often develops central clearing – Center may be vesicular or necrotic

  • Treated with doxycycline (>8 yrs) or

amoxicillin (<8 yrs)

DermAtlas

slide-14
SLIDE 14

http://www.cdc.gov/lyme/stats/maps/map2013.html

slide-15
SLIDE 15

Hair Loss

slide-16
SLIDE 16

Hair Loss

  • Acquired vs. congenital
  • Localized vs. generalized
  • Nonscarring vs. scarring
slide-17
SLIDE 17

“Black-dot” hair

slide-18
SLIDE 18

Inflammatory form Seborrheic form

Tinea Capitis

slide-19
SLIDE 19

Tinea Capitis: Treatment

  • Oral medication:

– Griseofulvin: 20 mg/kg/d of the microsize preparation for 8 weeks – Terbinafine: <25 kg: 125 mg/d, 25-35 kg: 187.5 mg/d, >35 kg: 250 mg/d for 4-6 weeks

  • Selenium sulfide 1% or 2.5% used as a shampoo

every other day for 2 weeks

  • May return to school after treatment begun
  • Return in 3-4 weeks to assess response to

treatment

slide-20
SLIDE 20

Krowchuk DP, Mancini AJ, eds. Pediatric Dermatology. A Quick Reference Guide. 2nd ed.

Traction

Symmetrical hair loss at sites of tension on hairs

slide-21
SLIDE 21

Alopecia Areata

  • Complete or nearly

complete hair loss

  • Scalp appears normal
slide-22
SLIDE 22

Hair- Pulling Disorder

  • Incomplete hair loss
  • Within affected

areas hairs are of differing lengths

  • Hemorrhage at

site of pulled hairs

slide-23
SLIDE 23

Light Spots

slide-24
SLIDE 24
  • Reduction (not total

loss) of pigmentation

  • Gradual transition from

normal to abnormal color

slide-25
SLIDE 25

Pityriasis Alba

  • Postinflammatory hypo-

pigmentation

  • Often becomes more apparent

after sun exposure

  • Treated with a low-potency

topical corticosteroid

  • Pigment normalizes in months
slide-26
SLIDE 26

Vitiligo

  • Loss of all skin color (i.e.,

depigmented)

  • Sharp border between

normal and abnormal color

slide-27
SLIDE 27

Well-defined hypo- pigmented macules (i.e., sharp borders)

slide-28
SLIDE 28

Tinea Versicolor

  • Superficial yeast infection
  • Affects adolescents and young

adults

  • Treated with selenium sulfide

topically (or fluconazole or itraconazole orally)

slide-29
SLIDE 29
slide-30
SLIDE 30

Seborrheic Dermatitis

  • Inflammatory response to

superficial yeast infection

  • Treatment:

– Scalp: antiseborrheic shampoo (e.g., selenium sulfide, zinc pyrithione) – Skin: low-potency topical corticosteroid or topical imidazole

DermAtlas

slide-31
SLIDE 31

A 9-year-old girl has been treated twice with permethrin for head lice. On examination you find lice and nits. What treatment might you advise?

slide-32
SLIDE 32

Diagnosis

  • Lice may be difficult to identify

– Move quickly (6 – 30 cm/min) – Avoid light – May blend into surroundings – May be few in number (average 10)

  • Viable eggs

– Match hair color of affected individual (appear white when empty) – Usually located within 1 cm of scalp

DeVore CD, et al. Pediatrics 2015;135:e1355-e1365 CDC, Public Health Library

Viable egg

Nymph about to emerge

Empty egg

slide-33
SLIDE 33

Using Permethrin

  • Shampoo with a nonconditioning shampoo, rinse, towel

dry

  • Apply permethrin for 10 minutes then rinse
  • Since 20% to 30% of eggs are not killed and eggs hatch in

8-9 days (range 7-12 days) repeat treatment in:

– 7-10 days (9 optimal based on life cycle of louse) – 7, 13-15 days

DeVore CD, et al. Pediatrics 2015;135:e1355-e1365

slide-34
SLIDE 34

Second-Line Treatments

Drug Rx/OTC Mechanism of Action Cost Ovide (malathion) Rx Neurotoxic1 $132.99 for 2 oz2 Sklice (ivermectin) Rx Neurotoxic4 $272.67 for 4 oz2 LiceMD (dimethicone) OTC

  • Facilitates lice removal
  • May block respiratory

apparatus $13.99 for 4 oz3 Natroba (spinosad) Rx Neurotoxic4 $178.55 for 4 oz2 Ulesfia (benzyl alcohol) Rx Paralyzes respiratory apparatus4 $60.58 for 8 oz2

1 potentially flammable 2 goodrx.com, 2/12/15 3 drugstore.com, 2/12/15 4 approved for those >6 months of age

Oral ivermectin

  • 200 mcg/kg once and again in 10 days
  • NOT FDA approved
  • Don’t use <5 years, <15 kg
slide-35
SLIDE 35

Treatment Facilities

  • Offer treatments on site or in your home
  • Treatments employ combing combined with a topical

nonpesticide mousse or heat

  • Cost: begins at $85
slide-36
SLIDE 36

Heat for Head Lice

  • Compared 6 heat-based

treatment methods in 169 subjects

% Louse Mortality % Egg Mortality Bonnet dryer 10.1 88.8 Blow dryer 55.3 97.9 Louse Buster 80.1 (88.2) 98 (99.2)

Goates BM, et al. Pediatrics 2006;118;1962-1970 Bush SE, et al. J Med Entomol 2011;48:67-72

Air Allé

slide-37
SLIDE 37
  • Erosion (from

scratching)

  • Lines of skin stress are

prominent (lichenification)

Atopic Dermatitis

slide-38
SLIDE 38

Appearance

slide-39
SLIDE 39

Appearance

DermAtlas

Erythema less evident Eruption papular

slide-40
SLIDE 40

Children and Adolescents

slide-41
SLIDE 41

Adolescents

DermAtlas

slide-42
SLIDE 42

Adolescents

DermAtlas

Dyshidrotic eczema: pruritic vesicles on sides of fingers

slide-43
SLIDE 43

Genetics

  • Mutations of genes coding epidermal

proteins (FLG) and cytokines (SPINK5)

Epidermal Barrier Dysfunction

  • Increased penetration of allergens

and irritants; bacterial colonization

  • Increased water loss, dry skin

Staphylococcus aureus

  • Cell wall components, superantigens,

and enterotoxins amplify the inflammatory response

Immune dysregulation

  • Abnormal cellular infiltrate and

cytokine production initiate and perpetuate inflammation

  • Decreased antimicrobial peptides
  • Avoid irritants
  • Emollient
  • Breastfeeding
  • Topical steroid
  • Bleach baths
slide-44
SLIDE 44

Rash in a Line

slide-45
SLIDE 45

Contact Dermatitis: Poison Ivy

slide-46
SLIDE 46

Fine erythematous papules Linear arrangement

slide-47
SLIDE 47

Herpes Zoster

slide-48
SLIDE 48

DermAtlas

Psoriasis

DermAtlas

Lesions at sites of trauma (Koebner phenomenon)

slide-49
SLIDE 49

Rash All Over

slide-50
SLIDE 50

CDC Public Health Image Library http://phil.cdc.gov/phil/home.asp

Petechiae

  • n palate

Rash composed

  • f fine, rough, red

papules

slide-51
SLIDE 51

Scarlet Fever

  • Infection with strains of

Streptococcus pyogenes that produce an erythrogenic toxin

  • Begins with symptoms of

streptococcal pharyngitis

– Sore throat – Fever – Headache – Abdominal pain or nausea

slide-52
SLIDE 52

DermAtlas

Erythema may be less noticeable in those more deeply pigmented Rash often concentrated in skin flexures

slide-53
SLIDE 53

Scarlet Fever - Treatment

  • Amoxicillin: 50 mg/kg (max 1 g) once daily for 10 days
  • Penicillin V bid-tid for 10 days:

– <27 kg: 250 mg; >27 kg: 500 mg

  • Benzathine penicillin G IM once:

– <27 kg: 600,000 units; >27 kg: 1.2 million units

  • Azithromycin or cephalexin if penicillin allergic
slide-54
SLIDE 54
slide-55
SLIDE 55

Erythema Infectiosum (Fifth Disease)

  • Most common manifestation of parvovirus B19 infection
  • Prodromal symptoms (low-grade fever, HA, and URI

symptoms) may be present

  • Rash begins on the face (“slapped-cheek” appearance)

with rapid spread to the trunk and extremities

  • Rash resolves in 1-3 weeks but may return with sun or

heat exposure, exercise

slide-56
SLIDE 56

Erythema Infectiosum: Complications

  • Arthritis: 60% of adolescents and adults
  • Transient aplastic crisis: in those with sickle cell disease
  • r other hemolytic anemia
  • Fetal hydrops or demise:

– Risk: 5% if not immune – Refer pregnant women exposed to parvovirus B19 to their

  • bstetrician
slide-57
SLIDE 57
slide-58
SLIDE 58

Pityriasis Rosea

  • Clinical:

– Patients usually well (5% have malaise, headache, sore throat) – Herald patch in 50-80% – 2-21 days later a generalized eruption occurs – Eruption lasts 2-12 weeks

  • Treatment:

– Antihistamine, topical corticosteroid, counterirritant (emollient with camphor or menthol) for pruritus – UV light

slide-59
SLIDE 59

Pityriasis Rosea

DermAtlas

Scale at trailing edge

  • f lesion
  • Lesions usually
  • val
  • Aligned parallel to

lines of skin stress

slide-60
SLIDE 60

Pityriasis Rosea

On the back, the arrangement of lesions mimics the appearance

  • f the branches of a fir tree.
slide-61
SLIDE 61

You are evaluating a child who

has fever, cough, conjunctivitis, rhinorrhea, and a generalized erythematous macular and papular rash.

M Rimsza

slide-62
SLIDE 62

http://www.cdc.gov/measles/cases-outbreaks.html

slide-63
SLIDE 63

http://www.cdc.gov/measles/cases-outbreaks.html

slide-64
SLIDE 64

Measles

  • Incubation: 8-12 days
  • Prodrome: lasts 3-5 days,

characterized by low-grade fever, cough, coryza, conjunctivitis

  • Koplik spots:

– Gray-white dots with surrounding erythema – Initially located adjacent to lower molars – Appear 2-3 days after symptoms begin (1-2 days before rash) – Resolve by day 2-3 of rash

slide-65
SLIDE 65

Measles Exanthem

  • Begins as faint macules

located along the lateral aspects of neck, hairline

  • Spreads within a day to

face, trunk, upper extremities

  • By day 2-3, rash begins to

fade on face and reaches feet

slide-66
SLIDE 66

Bumps

slide-67
SLIDE 67
slide-68
SLIDE 68

Molluscum Contagiosum

  • Infection with the

Molluscipox virus

  • Spread by direct contact,

fomites, autoinoculation

  • Resolves spontaneously
  • Lesions are translucent

papules that may have a central umbilication

slide-69
SLIDE 69

Molluscum Contagiosum

Dermatitis near lesions is common An enlarging, red lesion often is the result of immune activation (not infection)

slide-70
SLIDE 70

Molluscum Contagiosum

Remember the Koebner phenomenon?

slide-71
SLIDE 71

When Will It Go Away?

  • Mean time to resolution: 13.3 months

– Lesions present in 30% of patients at 18 months, 13% at 24 months

  • In 41% of families with multiple children, one or

more other children were affected

Olsen JR, et al. Lancet Infect Dis 2015;15:190-195.

slide-72
SLIDE 72

Treatment Options

  • No intervention
  • Cantharidin
  • Cryotherapy
  • Curettage
  • Imiquimod
  • Tretinoin
  • Salicylic acid
  • Topical corticosteroid if

surrounding dermatitis

slide-73
SLIDE 73

Unproven Therapies

Markum E, Baille J. Combination of essential oil of Melaleuca alternifolia and iodine in the treatment of molluscum contagiosum in children. J Drugs Dermatol 2012;11:349-354.

slide-74
SLIDE 74
  • Rough surface
  • Thrombosed

capillary

slide-75
SLIDE 75

Warts

Plantar Warts

Slide Atlas of Pediatric Physical Diagnosis

Periungual Wart

slide-76
SLIDE 76

Warts

Common Warts Flat Warts

DermAtlas

slide-77
SLIDE 77

Treating Common or Plantar Warts

  • Keratolytic (cure rate: 75% [48% for

controls])

  • Cryotherapy (cure rate: 80% in 12

weeks after 2-4 treatments)

  • Cantharidin
  • Imiquimod (Aldara)
slide-78
SLIDE 78

Using Keratolytics

  • Apply medication to wart and allow to dry
  • Cover with Band-Aid or tape
  • In the morning (or in 24 hours) wash the area and dry
  • Using an emery board or pumice stone, debride the wart
  • Repeat above steps
slide-79
SLIDE 79

Crusted Rashes

slide-80
SLIDE 80
slide-81
SLIDE 81

Crusted Impetigo

  • Cause: infection with Staphylococcus aureus
  • Clinical: erosions with a “honey-colored” crust typically

located around the nares

  • Treatment:

– Topical: mupirocin (Bactroban), retapamulin (Altabax) – Oral: first-generation cephalosporin (e.g., cephalexin), trimethoprim-sulfamethoxazole, clindamycin

slide-82
SLIDE 82

Erosion Remnant of scale

slide-83
SLIDE 83

Bullous Impetigo

  • Cause: infection with S. aureus

strains that produce an epidermolytic toxin

  • Clinical: vesicles or bullae rupture

leaving round or oval erosions

  • Treatment: first-generation

cephalosporin (e.g., cephalexin), trimethoprim-sulfamethoxazole, clindamycin